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Background: Tissue adhesives are useful means for various medical procedures. Since varying requirements cause
that a single adhesive cannot meet all needs, bond strength testing remains one of the key applications used to
screen for new products and study the influence of experimental variables. This study was conducted to develop
an easy to use method to screen and evaluate tissue adhesives for tissue engineering applications.
Method: Tissue grips were designed to facilitate the reproducible production of substrate tissue and adhesive
strength measurements in universal testing machines. Porcine femoral condyles were used to generate
osteochondral test tissue cylinders (substrates) of different shapes. Viability of substrates was tested using PI/FDA
staining. Self-bonding properties were determined to examine reusability of substrates (n = 3). Serial measurements
(n = 5) in different operation modes (OM) were performed to analyze the bonding strength of tissue adhesives in bone
(OM-1) and cartilage tissue either in isolation (OM-2) or under specific requirements in joint repair such as filling cartilage
defects with clinical applied fibrin/PLGA-cell-transplants (OM-3) or tissues (OM-4). The efficiency of the method was
determined on the basis of adhesive properties of fibrin glue for different assembly times (30 s, 60 s). Seven randomly
generated collagen formulations were analyzed to examine the potential of method to identify new tissue adhesives.
Results: Viability analysis of test tissue cylinders revealed vital cells (>80%) in cartilage components even 48 h post
preparation. Reuse (n= 10) of test substrate did not significantly change adhesive characteristics. Adhesive strength of
fibrin varied in different test settings (OM-1: 7.1 kPa, OM-2: 2.6 kPa, OM-3: 32.7 kPa, OM-4: 30.1 kPa) and was increasing
with assembly time on average (2.4-fold). The screening of the different collagen formulations revealed a substance with
significant higher adhesive strength on cartilage (14.8 kPa) and bone tissue (11.8 kPa) compared to fibrin and also
considerable adhesive properties when filling defects with cartilage tissue (23.2 kPa).
Conclusion: The method confirmed adhesive properties of fibrin and demonstrated the dependence of adhesive
properties and applied settings. Furthermore the method was suitable to screen for potential adhesives and to identify a
promising candidate for cartilage and bone applications. The method can offer simple, replicable and efficient evaluation of
adhesive properties in ex vivo specimens and may be a useful supplement to existing methods in clinical relevant settings.
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Tissue adhesives are very useful means in a wide variety
of medical procedures such as skin and wound closure
[1], vascular repair [2,3], bone piece fixation in osteosur-
gery [4], and fixation of biomaterials and engineered
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reproduction in any medium, provided the orSeveral factors influence the success and efficacy of a tis-
sue adhesive like the biocompatibility, biodegradability,
cost, availability and the tissue bonding properties [6].
Standardized methods to determine the strength proper-
ties of tissue adhesives are made available by standard
bodies like the American Society of Testing and Materi-
als (ASTM). These methods provide means for compari-
son of adhesive strength of tissue adhesives in tension,
and in lap-shear or t-peel by tension loading (ASTM test
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ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Dehne et al. BMC Musculoskeletal Disorders 2012, 13:175 Page 2 of 9
http://www.biomedcentral.com/1471-2474/13/175simple structure of these experimental setups covers a
broad range of medical bonding problems useful for test
substrates from various tissues. Unfortunately, such test
conditions often do not sufficiently reflect the biological
complexity and the variety of the individual application
resulting in a limited predictive power for in vivo testing.
Therefore, the development of test methods still remains
a key aspect in searching for new tissue adhesives.
In cartilage tissue engineering (TE) the fixation of tis-
sues and transplants in the knee cavity represents a
particular challenge, due to the complex mechanical
loading condition. Fibrin glue has been widely-used [5],
but it still has drawbacks like the danger to spread dis-
eases [7] and cause allergenic reactions [8], and, particu-
larly, a non-sufficient adhesive strength [9,10]. Hence
there is still a high demand for alternative products.
Apart from test methods relating to ASTM, several test
methods have been developed to determine adhesive
strength in joint tissues. Reindel et al. developed a method
to analyze the integrative repair and the adhesive strength
at glued cartilage-cartilage interfaces based on thin cartil-
age stripes [11]. Jürgensen et al. chose for the same pur-
pose osteochondral cylinders [12]. Hunter et al. developed
an easy to handle in vitro cartilage repair model to analyze
the integration and maturation of transplants [13]. Sierra
et al. determined the failure characteristics of multiple-
component adhesives [14]. Since these studies mainly
focus on bonding properties of newly developed adhesive
materials rather than the method itself, the description is
often not sufficient to adequately reproduce. The employed
equipment is customarily very complex and costly and
demands a high level of technical experience and practice.
On the basis of previously published methods and
existing standards we developed a method to screen and
evaluate tissue adhesives intended for fixating tissues
and transplants for joint repair applications. The method
employs viable osteochondral tissue from porcine fem-
oral condyles to capture aspects of joint repair applica-
tions such as bonding on cartilage and bone tissue, and
surgical fixation of tissues and transplants in joint
defects. The methodical approach involved steps like the
generation of test tissues and the detailed presentation
of used equipment and force measurement protocols
resulting in an easy to use method for replication. The
efficiency of this methodology was demonstrated for the
adhesive properties of fibrin glue. A screening of differ-
ent collagen formulations was performed to demonstrate
the potential of the method to identify adhesive candi-
dates for joint repair applications.
Results
Viability of tissue cylinders
To check whether prepared substrate tissue cylinders are
still in viable condition, cell viability test with cartilagespecimen was conducted 48 hours post preparation.
Fluorescence microscopy of stained tissue specimen
showed viable (green) and apoptotic (red) cells (Figure 1).
Histomorphometric analysis of captured images was used
to determine the percentage of apoptotic cells. Independ-
ent from substrate type (plane cartilage, cartilage defect
cylinder or cartilage disc) more than 80% of the cells
were found viable (<20% apoptotic) after 48 hours dem-
onstrating high viability of prepared substrates for
testing.
Adhesive characteristics of fibrin glue
Medical grade fibrin glue was used to test the different
operation modes at different assembly times (30 s, 60 s).
Except for the fixation of the cartilage disc in the defect
(pull-out cartilage, Figure 2a) the adhesive strength of
fibrin glue was increasing with assembly time.
Varying adhesive strengths were detected in the spe-
cific tests. Highest values were obtained in pull-out test
systems. Inserted cartilage was fixed by fibrin with an
adhesive strength of nearly 30.1 kPa after 30 s assembly
time (60 s: 26.5 kPa; -1.1-fold vs. 30 s), fibrin/PGLA-
cell-transplant resisted up to 33.7 kPa after 30 s and
about 47.2 kPa in average after 60 s (1.4-fold vs. 30 s).
After 30 s bonding time, adhesive strength between car-
tilage surfaces (5.2 kPa) was significantly lower than after
60 s (24.6 kPa; 4.9-fold). In bone tissue lowest adhesive
strength of all four applied systems was detected after
30 s (2.6 kPa), which was significantly increased after 60
s (12.1 kPa, 4.7-fold). For all measurements a mixture of
adhesion and cohesion failure was observed. In total, ad-
hesive strength of fibrin was increasing with assembly
time on average of all operation modes (2.4-fold). Sub-
strate failures have not occurred.
Reusability of substrates was investigated with three sets
of cartilage cylinders. During repeated use no significant
differences were observed compared to freshly prepared
cylinders (p= 0.683, Figure 2b).
Screening for potential tissue adhesives
The test system was used to identify potential tissue adhe-
sives. Since collagen represents a promising material due
to its biocompatibility and capability to form a natural
bonding to the surrounding tissue, the screening was con-
ducted with seven different formulations and recipes of
collagen preparations from porcine skin. The assembly
time was kept short (30 s) since preliminary experiments
have shown that adhesive strength of collagens did not
change with time (<1.1-fold vs. 60 s and 0 s).
Collagen sample 3 demonstrated significant higher adhe-
sive properties in cartilage (14.8 kPa) and bone tissue (11.8
kPa) compared to fibrin glue (2.6 kPa; 5.2 kPa, Figure 3). In
the model filling defects with cartilage (pull-out cartilage)
the detected adhesive strength of sample 3 (23.2 kPa) was
Figure 2 Establishing the test system. (a) Different modes of
operation were applied to determine adhesive characteristics of
fibrin. Varying bonding strengths were detected in the specific tests
with highest values in fixing transplants and lowest in bonding
bone tissue. T-test: 30 s vs. 60 s, * p < 0.05. (b) The reusability of
tissue cylinders was investigated for cartilage. Three different
biological replicates (set 1–3) of cartilage cylinders were investigated.
After each measurement with fibrin, the adhesive was removed and
a new control measurement with PBS was performed. This
proceeding was repeated 10 times. Technical variations for each set
range from 0.4 and 2.4 kPa, but do not increase with frequency of
use suggesting that the cylinders can be reused. Differences
according to biological variation are marginal (mean values range
from 1.16 – 1.34 kPa, grey bar) demonstrating good reproducibility
of the preparation method.
Figure 1 Viability of substrate tissue. (left) Sections of PI/FDA-stained cartilage components from (i) leveled and (ii) hole-punched substrate
cylinders, and (iii) cartilage discs were analyzed by fluorescence microscopy. Viable cells appear green and apoptotic cells red. (right)
Histomorphometric analysis was performed to determine the percentage of apoptotic cells as measure for the viability of the tissue. For each
image areas of different red tones were determined and presented in new colors. High content of apoptotic cells was indicated in red, moderate
in orange, low in yellow and areas with high content of viable cells were shown in green (see Methods). Only a small proportion of cells was
found apoptotic (<18%), hence 48 h post preparation cartilage components of the substrates are in a viable condition for adhesive strength
measurements. Bar = 200 μm.
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pull-out transplant assembly no collagen formulation was
competitive with the adhesive properties of fibrin
(Figure 3).
Discussion
In an effort to quantify the adhesive bonding strength of
potential medical adhesives, it is important to develop
consistent and reproducible test methods for evaluation
and comparative purposes. Since adhesives will be used
on living tissue, a readily available test system is pre-
ferred. Available methods range from highly standar-
dized methods with less consideration of biological
aspects to tests on animal models reflecting the full
complexity of a surgical problem [15].
Based on previously published methods [11-13] and
on our knowledge with engineered tissues, we designed
a test method providing the means to determine adhe-
siveness in bone and cartilage tissue. The complexity
and individuality of differing applications imply that the
results of a single test are not suitable for determining
adhesive properties without thorough analysis and
understanding of the application and adhesive behaviors.
Therefore, test conditions have been developed consider-
ing surgical procedures such as the fixation of tissue and
tissue engineered transplants in cartilage. Thus, not only
the strength properties of the tissue adhesive at the
bonding layer are considered, but also those of adher-
ends and the behavior at the interface [16]. For bonding
problems involving different tissues like bone and cartil-
age in joint repair, strength measurements with bone
and cartilage substrates in isolation facilitate the identifi-
cation of weaknesses and strength of adhesives, and
hence, can contribute to improvements of the bonding
material.
To test the bonding properties of tissue adhesives
under in vivo-like conditions, vital porcine osteochondral
tissue cylinders were used. Viability of the tested tissue
Figure 3 Screening for potential adhesives. Screening was performed in different operation modes (see Figure 3). Sample 3 demonstrated
higher bonding strength than fibrin when used on cartilage and bone tissue. In settings filling “artificial defects” with cartilage tissue or TE
transplants, fibrin showed highest bonding strength. These results demonstrate high bonding properties of fibrin in all settings. Sample 3 can be
identified as potential tissue adhesive that is not suitable for fixing fibrin-based TE transplants. T-test vs. fibrin, * p < 0.05.
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ity of the fabrication process for the generation of sub-
strate tissue comprising vital cells. Tissues from bovine,
ovine and porcine cylinders are preferred due to the easy
availability and the fact, that relatively large samples can
be harvested from a single source. The application of
standard shape tools such as hole punches and tissue
holders ensured the fabrication of substrate tissues with
reproducible shape. For fibrin testing at cartilage surfaces
the possible reusability of the prepared tissue was
demonstrated. Although not meeting the high standards
of material testing, the use of non-homogeneous (bio-
logical) material can be beneficial with regard to interac-
tions between adhesive and tissue.
The efficiency of the method was shown on the basis
of adhesive properties of fibrin glue. The varying results
in the different test modes demonstrate that adhesives
pose specific bonding properties closely related to the
geometry of the applied setting. Both pull-out settings,
providing a cavity filled with tissue or transplant, seem
to be advantageous for fibrin, whereas blunt ends of the
tissue on tissue settings are apparently not appropriate
to exploit the adhesive potential of fibrin. Although diffi-
cult to compare with other studies, Sierra et al. deter-
mined similar bonding properties (around 30 kPa) for
commercially available fibrin glue [14] confirming results
obtained from pull-out settings. In accordance with the
time dependent polymerization of fibrinogen [17], the
test method was able to identify differences in adhesive
strength after 30 s and 60 s assembly time. Since the col-
lagen formulations have shown higher adhesiveness in
preliminary experiments and to limit the experimentaleffort, screening experiments were performed only for
the short time period.
We observed a mixture of adhesion and cohesion
failure when fibrin was tested. Adhesive and cohesive
strength determine the bonding effectiveness and can
give information about adhesive properties. Ideally,
cohesive failure occurs through the insufficient internal
strength of the adhesive. Breaks can indicate brittleness
and deformations are characteristic for e.g. polymeric
elastics. Adhesion failure occurs if mechanical and inter-
molecular forces at the bonding layer do not resist the
load [16]. The type of failure is determined by the lower
strength. Combinations of both types can indicate inho-
mogeneities within the adhesive material or at the bond-
ing layer. The preparation of fibrin can easily lead to
inhomogeneities since fibrinogen and thrombin have to
be mixed before use by the operator. Furthermore,
irregularities at the substrate surface cannot be excluded
completely since biological materials naturally vary.
A screening of different collagen formulations was per-
formed to demonstrate the potential of the method to
identify a promising candidate. As comparative standard
fibrin glue was used, that is widely-used as adhesive in
surgery [5]. The results confirm the high bonding
strength of fibrin in tests filling defects such as fixing
transplants or tissues. Different collagen formulations
were generated using different extraction methods (urea,
pepsin) and downstream modifications (oxidation, con-
centration, mixture with hyaluronic acid sodium salt
(HA)). A test specimen extracted with pepsin and mixed
with HA (sample 3) demonstrated potent adhesive prop-
erties in cartilage and bone tissue, but was not suitable
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specimen extracted with pepsin (sample 5–7) or mixed
with HA showed no increase of adhesive strength sug-
gesting the formation of a unique complex between both
substances. Furthermore, the varying results in the dif-
ferent test assemblies demonstrate that adhesive proper-
ties are closely connected with the requirements, thus, a
test method has to be adapted as best to the condition
of the intended application.
Generally, the method can be easily changed to torsion
and shear measurements applying another force mea-
surements device capable of it. The method was kept
simple and all used equipment can easily be obtained
from local providers and collaborators. The preparation
technique is easily translatable to other models with
comparable dimensions of joints like horse, goat and
sheep [18-20]. The use of human tissue would be favor-
able but will be most likely not be in line with ethical
considerations. Generally, the data generated from a
testing method on biological tissue may vary from that
found in vivo, however, testing results can offer valuable
information on the potential bonding capacity and the
preparation of subsequent in vivo experiments.
Conclusion
The method represents a useful supplement to existing
methods to determine adhesive strength in viable tissues
in clinical relevant settings, even though not all medical
procedures for cartilage or bone surgeries and TE-based
interventions are covered. The method was kept simple
and replicable since universal equipment was applied
and detailed protocols were provided. Different test
modes confirmed the dependence of bonding properties
and applied settings further justifying individual test
methods in addition to standard testing. Finally, the pre-
sented method was suitable to screen potential adhesives
and to identify a promising candidate for cartilage and
bone applications.Figure 4 Tissue grips. Pictures and technical drawings of grips used for (a
measurements.Methods
Custom-made equipment
Tissue grips for substrate tissues were made of alu-
minum or stainless steel. The grip for the preparation of
tissue cylinders was designed to fit with its external
dimensions to the jig of a standard microtome device.
The inner bore diameter (10 mm) is matching the diam-
eter of a tissue cylinder ensuring plane cutting of cylin-
der ends (Figure 4a).
The grip for force measurements comprises a cylindrical
hole to hold the completed test tissue cylinders. Since
tensile and compressive forces do appear during
measurements, additional screws ensure adherence to
exact position. The other site of the holder was
designed to fit into the jig of a force measurement device
(Figure 4b).
Preparation of test substrate cylinders
To test the bonding properties of tissue adhesives in envir-
onments reflecting situations in joint repair, bone and car-
tilage tissue cylinders are used. Therefore, femur bones
from 6–10 month-old porcine donors (100–130 kg) were
purchased from a local slaughterhouse (Figure 5a). During
transport to the laboratory (<3 hours) the condyle was
kept covered with the meniscus preventing the cartilage
from drying. For further processing, covering tissues were
removed and bare condyles were cut off using a rotary
reciprocating saw (Oscillant E, Aesculpap, Germany,
Tuttlingen). The removed discs were 1–1.5 cm thick and
3–5 cm in diameter depending on the shape and the size
of the condyle (Figure 5b). The discs were used for the
preparation of the raw tissue cylinders. Accordingly, a 10
mm hole punch (ConnexW, Conmetall, Germany, Celle)
was used and agitated using a bench vice (Heuer,
Germany, Plettenberg) to apply a controlled load force or-
thogonally to the sectional plane (Figure 5c). To obtain
even ends tissue cylinders were cut using a custom-made
tissue grip (as described above) exactly fitting into the) substrate tissue cylinder preparations and (b) adhesive strength
Figure 5 Preparation of substrate tissues. Schematic graphs and pictures illustrating the preparation of substrate tissue cylinders used for the
determination of bonding strength. Osteochondral discs of 1–1.5 cm thickness (b) were obtained from the lateral and medial condyle of pig
femoral bones (a) using a rotary reciprocating saw. (c) The removed discs were hole-punched to generate a cylindrical tissue specimen with a
diameter of 10 mm. A bench vise facilitated a controlled agitation of the punch orthogonal to the sectional plane. (d) The raw tissue cylinder was
placed in a customized grip that is fitting into the jig of a standard microtome device (see also Figure 4a). (e) Using the blade of the microtome
the surface of the tissue cylinder was leveled to obtain regular bone or cartilage cylinder ends. Thus, starting from a raw cylinder (d), cartilage
and bone substrate cylinders with plane surfaces can be generated (h). Furthermore, with the help of a smaller punch (ø 6 mm) another hole
was created (f) providing an artificial cartilage defect to be filled with cartilage tissues or transplants (g, i).
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Germany, Wetzlar) (Figure 5e).
Finally, using raw tissue cylinders as a basis
(Figure 5d), it was possible to create plane cartilage and
bone tissue cylinders useful to mimic the fixation of
these tissues (Figure 5h). Additional cut-outs on raw
cylinders with a hole punch ( 6 mm Aesculap,
Germany, Tuttlingen) were done to generate defined
artificial defects (Figure 5f ). For adhesive testing, these
defects are either filled with cartilage tissue discs
obtained from the previous cut-out step or with TE
transplants described below (Figure 5g, h). Completed
tissue cylinders were maintained until use in chondro-
cyte culture medium described below.
Test of viability
Test substrate cylinders were examined for tissue viability
on 0.5 mm cartilage slices involving propidium iodide/
fluorescein diacetate staining (PI/FDA; Sigma-Aldrich,
Germany, Taufkirchen) before use in adhesive strength test-
ing (48 hours post preparation). Washing steps were doneusing PBS (Biochrom). The staining was performed first in
FDA solution (3 μg/ml; 15 min, 37°C) and subsequently in
PI staining solution (100 μg/ml; 2 min; RT). For microscopy
an Olympus CKX41 combined with a reflected fluores-
cence microscopy system was used (Olympus, Hamburg,
Germany). A histomorphometric analysis was performed to
determine the percentage of apoptotic cells as a measure
for the viability of the tissue. For each PI/FDA image the
percentage of red stained areas (pixel) was determined in
red-green-blue (RGB) color mode using a programming
software (Xcode, Apple Inc.). Since areas containing viable
and apoptotic cells appeared as mixed colors, different red
tones were discriminated. Areas with high red content (red
value × 0.8 >G value+B value) containing exclusively apop-
totic cells were weighted as 100% apoptotic. Areas with
moderate content (R × 1.0 >R+B) were weighted 50% and
with low red content (R × 1.2 >R+B) 25%. Areas with
other colors (R × 1.2 <= R+B) were considered as viable.
After RGB analysis an image was created visualizing the
discriminated areas in different colors (high – red; moder-
ate – orange; low – yellow, other – green).
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Transplants were generated adhering to protocols already
published and clinically applied for matrix associated chon-
drocyte implantations [21]. Briefly, chondrocytes wereFigure 6 Modes of operation. For measuring adhesive strength in bone
other. For tissues and transplants a cylindrical indenter was placed opposin
cyanoacrylate glue to facilitate a strong bonding between steel tip and ins
with the test adhesive, opposite sites were joined under defined initial load
separated with constant speed until rupture. This pulled the inserted tissue
strength was recorded over time. The maximum bonding strength (τmax) w
subtracted. The bonding strength was calculated from difference betweenenzymatically isolated from porcine femoral condyle cartil-
age. Cells were sub-cultured in medium (DMEM, Bio-
chrom, Germany Berlin) containing 10% FBS (Biochrom).
For storage cells were frozen in 10% DMSO supplemented(a) or cartilage tissue (b), two cylinders were placed opposite to each
g the inserted tissue (c) or transplant (d). The tip was coated with
erted tissue or transplant after contact. After preparing the surfaces
(e.g. 0.5 N). Once bonding time was reached opposite sites were
or transplants out of the “artificial defect”. (e) The progress of adhesive
as determined and the mean value of the base line signal was
“no template control” (NTC) and sample value.
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nitrogen until use. For transplant generation cells were
thawed, sub-cultured for two weeks, and resuspended in
media containing fibrinogen (33% v/v, Tissucol Duo S,
Baxter, Germany, Unterschliessheim). The cell suspension
was loaded and incorporated into bioresorbable co-polymer
fleeces of poly(lactic-co-glycolic acid) (PLGA, 6 mm diam-
eter, Ethicon, Germany). Addition of thrombin (10% v/v in
PBS, Tissucol Duo S) led to polymerization to fibrin result-
ing in a ready-to-use fibrin/PLGA-cell-transplant.Determination of the adhesive strength
To determine the adhesive strength, a tensile test was
performed. The strength of the bonding was determined
using a Zwick Z005 universal testing machine (Zwick
GmbH, KG, Germany, Ulm) equipped with 50 N load
cell (AST GmhH, Germany, Dresden). The adhesive as-
sembly (test substrate + adhesive) was held at 0.5 N con-
tact load at room temperature for different contact
times. Jointing components were merged with a speed of
10 mm/min until contact load was reached. After reach-
ing assembly time, jointing components were pulled
apart until rupture at a nominal speed of 5 mm/min
while recording load and time. Equal volumes of fibrino-
gen and thrombin (20 μl each, Baxter) were applied
separately on substrate tissue surfaces immediately be-
fore starting the measurement sequence. For candidate
screening 20 mg material were used. For fibrin and can-
didate testing at least 5 repetitions were performed with
freshly prepared adhesive specimen and substrates. To
test the reusability of tissue substrates, three cartilage cy-
linder sets were used, which were reused up to 10 times.Modes of operation
For the determination of bonding strength, different
modes were applied reflecting specific requirements in
joint repair. For bone on bone (Figure 6a) and cartilage
on cartilage (Figure 6b) settings, cylinders were placed
opposite to each other and the exclusive adhesiveness on
separate tissues was determined. For simulating the fill-
ing of cartilage defects, pull-out experiments for cartil-
age tissue (Figure 6c) and fibrin/PLGA-cell-transplants
(Figure 6d) were performed. A cylindrical steel tip
(custom-made, diameter 5 mm) was used as indenter
and was placed opposite the inserted tissue or trans-
plant. The indenter tip was coated with cyanoacrylate
glue (HistoacrylW, Braun, Germany, Melsungen) to imme-
diately connect indenter and sample after contact.
The bonding strength was calculated from maximum
bonding strength (τmax) subtracted with “no template con-
trol” (NTC) bonding strength determined with phosphate
buffered saline (PBS, Biochrom, Germany, Berlin). This
correction was performed for each series of measurement(Figure 1), since substrate tissues demonstrated low self-
adhesive properties.
Preparation of collagen formulations
For screening tests different collagen formulations were
randomly generated. Therefore, brine-conserved porcine
skin was separated from fat by acetone extraction and
concomitant proteins were removed through extraction
with a solution containing sodium chloride (6% w/v) and
formic acid (1% w/v). Collagen extraction was achieved
either through extraction with 6M urea (samples 1, 2 and
4), or through exposure to 5% pepsin (samples 3, 5–7).
Except sample 3 pepsin-extracted specimens were further
oxidized using sodium periodate (sample 5–7). Samples 6
and 7 were additionally crosslinked with adipic acid dihy-
drazide. Sample 7 was concentrated by ultrafiltration
before crosslinking. Sample 2 and 3 were mixed with same
volume of 0.2% hyaluronic acid sodium salt (CPN spol. s r.
o., Czech Republic, Dolní Dobrouc).
Statistical analysis
Significance level of pair wise group comparison has
been obtained applying t-test statistics of the SigmaStat
3.5 software package (Statcon, Germany, Witzenhausen).
If normality or equal variance test was not passed Wil-
coxon rank sum-test was conducted. A p-value lower
than 0.05 was considered significant.
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